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environmental factors and genetic predisposition. Auditory
hallucinations (AH) are a specific and disruptive symptom of
schizophrenia affecting around 70% of patients [1].
In order to identify gene expression biomarkers of auditory
hallucinations in schizophrenia, we have conducted a network-
based transcriptomic analysis of 45 individuals, 15 with AH (SA),
15 without AH (SNA) and 15 matched controls (CNT).
Gene expression data from blood samples were generated using
Affymetrix Human Gene 2.0 ST Genechips. The RMA normal-
ization method was applied for gene summarization and the most
variably expressed probesets (4,508) between subject (or
experimental) groups were selected. These dataset was analyzed
using the weighted gene co-expression network analysis
(WGCNA) package in R.
The gene co-expression network analyses identified 11 different
gene modules based on their topological overlap. These modules
were related to phenotypic information allowing us to identify
modules differentially expressed according with specific pheno-
typic traits.
To identify potential blood biomarkers of schizophrenia and
auditory hallucinations, we selected modules including genes
which expression differed significantly mainly in the three subject
groups (CNT, SNA and SA), but showing no changes due to the
other analyzed traits such as age or medication.
Next, we chose genes from the selected modules with a
high statistically significance (p < 0.01). A total of 15 genes were
found and differences in their expression in CNT, SNA and SA
samples were tested by RT-qPCR. We confirmed differences in
expression of two genes. The expression of the Eukaryotic
Translation Initiation Factor 2D gene (EIF2D) was increased in
schizophrenic patients versus controls p < 0.001. The expression
of the Thymocyte Selection-Associated HighMobility Group Box
gene (TOX) was reduced in the schizophrenic group p < 0.01.
To determinewhether the 15 evaluated genes or a subset of them
might be useful as biomarkers for schizophrenia, we interrogated
the expression of each of them (as fold change compared to control
average) using binary logistic regression. We obtained a predictive
equation in which the EIF2D and TOX gene expression could
differentiate schizophrenia patients versus controls: −0.106 +
[2.957 × EIF2D] + [−4.198 × TOX]. Applying this equation to
our sample, the schizophrenic patients could be separated from
healthy controls with 86.5% accuracy.
Then, we applied the same analysis to identify potential
biomarkers of AH. In this case, the expression of RNPS1, NRD1,
CPQ and APOBEC3G were able to differentiate between SA and
SNA with an 80.8% accuracy in our sample: 0.29 + [2.596 ×
RNPS1] + [−4.295 × NRD1] + [2.821 × CPQ] + [−2.586 ×
APOBEC3G].
Using a network-based transcriptomic analysis, we have
identified a set of genes that might be useful as blood biomarkers
of schizophrenia and auditory hallucinations. Moreover, these
genes pointed out new pathways involved in this disease.
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Background:Although the majority of suicides are committed by
psychiatric patients, suicide is a multicausal phenomenon with a
strong biopsychosocial background, including a significant
contribution of genetic factors. As suicide still contributes to a
large number of unnecessary, and possibly preventable deaths
worldwide, constituting the leading cause of death among young
males, we lack effective methods for predicting, screening, and
preventing suicide. Thus our aim is to develop a complex model
incorporating several levels of evidence from genetics through
biochemistry as well as social and psychosocial determinants of
suicidal behaviour. The 5-HTTLPR polymorphism of the
serotonin transporter gene has previously been implicated in
suicidal behaviour and violent completed suicides. The aim of our
present study was to investigate the association between 5-
HTTLPR and suicidal behaviour in our currently developing
suicide biobank.
Methods: During autopsy sample DNA samples were obtained
for 5-HTTLPR genotyping from 200 subjects deceased due to
suicide and 200 controls deceased due to other causes. Chi-square
tests and logistic regression analyses were performed according to
additive, dominant and recessive models to analyse the possible
association between 5-HTTLPR genotype distribution and
suicide.
Results: Ratio of violent and non-violent suicides was 81% and
19% in our suicidal subsample, respectively. No significant
difference was found in the distribution of 5-HTTLPR genotypes
between the suicidal and control samples according to any genetic
models (additive: χ2 = 0.602, p = 0.740; dominant: χ2 = 0.404;
p = 0.525; recessive χ2 = 0.457; p = 0.499). No difference
was found between violent and nonviolent suicides with respect
to genotype distribution within the suicidal sample (additive:
χ2 = 1.771, p = 0.412; dominant: χ2 = 1.555, p = 0.212; reces-
sive χ2 = 0.913; p = 0.339). Using logistic regression, a
significant association was found between sl genotype and
suicide at a younger age in the suicidal subsample according to
the additive model (OR = 1.037; p < 0.001; df = 1; B = 0.036).
Conclusions: Although our preliminary study found no
evidence for an association between 5-HTTLPR genotype and
suicide, a significant association was found between the sl
genotype and younger age at suicide, indicating an important role
of this genetic variant in the emergence of suicidal behaviour
which may deepen our understanding of the dynamics of suicide
risk and may help us identify targets for early screening and
intervention. Several limitations must be mentioned possibly
contributing to our negative results. Our control group included
subjects deceased due to accidents where suicidal intent cannot be
ruled out. Furthermore, due to a lack of suicidal autopsy we could
not gain data concerning psychiatric illness in our suicidal sample
and we could not gather information on distal and proximal life
stressors which are known to play a role in the effect of 5-HTTLPR
at least in depression. Given the difficulty of studying suicidal
behaviour due to the relatively low number of cases, our results
argue for the further development of our suicide biobank and the
investigation of further novel genotypes associated with endo-
phenotypes of suicidal behaviour in living subjects.
P.1.a Basic and clinical neuroscience – Genetics and epigenetics S581
